Show results for
Refine by
Colon Product Applications Available In In Europe
4 applications found
More Americans die each year from lung cancer than from prostate, breast and colon cancers ...
ByAuris Health, Inc. based in Redwood City, CALIFORNIA (USA)
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an assessment of the tumor immune response. ...
ByVeracyte based in Marseille Cedex 9, FRANCE
Cancer is one of the leading causes of deaths in India and a major public health concern. It is estimated that there are around 1 million new cancer cases every year and as many as 5 lakh deaths occur annually. Around 71% of all cancer deaths in India occur in people 30 to 69 years of age, when adults are very productive. The burden of cancer is expected to further increase due to increase in life expectancy, heavy use of tobacco and other risk factors such as radiation, viruses, ...
ByinDNA Research Labs based in , INDIA
Colorectal cancer is the third most commonly occurring cancer in men and the second most commonly occurring cancer in women. There were over 1.8 million new cases worldwide in 2018. Generally colorectal cancer is being treated with surgery by cutting away the diseased part in the rectum and joining the two new ends together resulting in an anastomosis (which is the resultant ...
BySafeHeal based in Paris, FRANCE